HPV genotype | Odds ratio | 95Â % CI | P value* |
---|---|---|---|
CD4 count < 200 cells/μl | |||
 HPV 16 | 0.7 | 0.2–1.9 | 0.4 |
 HPV 18 | 1.3 | 0.4–4.6 | 0.7 |
 HPV 31 | 1.1 | 0.3–4.4 | 0.9 |
 HPV 33 | 3.3 | 0.9–11.9 | 0.07 |
 HPV 35 | 2.4 | 0.7–8.3 | 0.2 |
 HPV 45 | 3.3 | 0.3–39.4 | 0.4 |
 HPV 51 | 1.5 | 0.4–5.6 | 0.6 |
 HPV 52 | 2.5 | 0.8 8.1 | 0.1 |
 HPV 53 | 4.4 | 1.4–13.6 | 0.01 |
 HPV 56 | 0.6 | 0.2–2.2 | 0.4 |
 HPV 58 | 2.6 | 0.7–8.7 | 0.1 |
 HPV 66 | 3.1 | 0.8–11.9 | 0.1 |
 HPV 68 | 0.6 | 0.06–6.2 | 0.7 |
 Multiple HPV co-infection | 3.7 | 1.2–12.1 | 0.03 |
CD4 count ≥350 cells/μl | |||
 HPV 16 | 2.9 | 1.0–8.3 | 0.05 |
 HPV 18 | 0.4 | 0.08–1.9 | 0.2 |
 HPV 53 | 0.6 | 0.2–2.1 | 0.4 |
 Multiple HPV co-infection | 0.7 | 0.3–2.0 | 0.5 |
Age ≥ 30 adjusted for sexual partners | |||
 HPV 16 | 1.1 | 0.3–4.1 | 0.8 |
 HPV 18 | 2.3 | 0.5–11.5 | 0.3 |
 HPV 53 | 0.9 | 0.2–3.2 | 0.8 |
 Multiple pHR/HR HPV infections | 2.4 | 0.7–8.9 | 0.2 |